CERo Therapeutics Holdings, Inc. (CERO) vs Virpax Pharmaceuticals, Inc. (VRPX)
CERo Therapeutics Holdings, Inc. and Virpax Pharmaceuticals, Inc. are both Biotechnology companies. Virpax Pharmaceuticals, Inc. is the larger, with a market value of $160.0K against $140.0K — 1.1× the size. Virpax Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. Across the 8 metrics below, CERo Therapeutics Holdings, Inc. leads on 6 and Virpax Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | CERO | VRPX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 453.76% | (2,364.98%) | (57.72%) |
| Return on assets | (2,352.32%) | (215.80%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack